Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Mod GRF, GHRP-6 10mg (Blend)

Mod-G6-10mg-BlendPeptide Blends Research dossier Positioning Mod GRF, GHRP-6 10mg (Blend) Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone. Most requested Research DossierMod-G6-10mg-BlendPeptide Blends Quick board SequenceN/A FormulaN/A Mol. WeightN/A 0 links Document-backed Pricing & access $95USD / dossier Explore next Related peptides Browse nearby entries from the full catalog, starting with Peptide Blends. Start with adjacent compounds, or send one straight to the assistant for a comparison prompt. Ask Assistant Description Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone. Mod GRF (CJC-1295 without DAC) stimulates cAMP/PKA-dependent GH synthesis, while GHRP-6 acts on the GHS-R1a receptor and triggers phospholipase C as well as calcium release. This dual-action

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Mod-G6-10mg-BlendPeptide Blends

Research dossier Positioning

Mod GRF, GHRP-6 10mg (Blend)

Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone. Most requested

Research DossierMod-G6-10mg-BlendPeptide Blends Quick board

SequenceN/A

FormulaN/A

Mol. WeightN/A

0 links

Document-backed

Pricing & access

$95USD / dossier

Explore next

Related peptides

Browse nearby entries from the full catalog, starting with Peptide Blends.

Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.

Ask Assistant

Description

Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone. Mod GRF (CJC-1295 without DAC) stimulates cAMP/PKA-dependent GH synthesis, while GHRP-6 acts on the GHS-R1a receptor and triggers phospholipase C as well as calcium release. This dual-action mixture is used in mechanistic studies on peptide receptor crosstalk, GH pulsatility, and modulation of the somatotropic axis.

Crawl paths

Fresh discovery

Jump from this product into the newest URLs, recent updates, and grouped hubs.

Peptide BlendsMar 7, 2026

CJC-1295 (no DAC), GHRP-2 10mg (Blend)

Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.

Purchase PeptidesMar 7, 2026

TB-500 10mg

Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.

CapsulesMar 2, 2026

5-Amino-1MQ 50mg (60 Capsules)

5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.

All PeptidesMar 2, 2026

Acetyl Hexapeptide-3 (Argireline) 200mg (Topical)

Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.

ArticleMar 10, 2026

Are Peptides Legal? A Country-by-Country Guide to Peptide Regulations

The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.

ArticleMar 10, 2026

BPC-157 Dosage Guide: Protocols, Timing, and Administration

Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.

References

Documentation

Supporting documents typically expected alongside the product profile.

This page is compiled from publicly available research material and normalized for browsing inside the catalog.

Connected topics

Follow this recovery question